Literature DB >> 6822426

Possible chemotaxis of human monocytes by N-acetylmuramyl-L-alanyl-D-isoglutamine.

T Ogawa, S Kotani, S Kusumoto, T Shiba.   

Abstract

N-Acetylmuramyl-l-alanyl-d-isoglutamine (MDP) induced the chemotaxis of human blood monocytes without mediation of serum complement. Specificity (dependency on chemical structure) of the chemotactic activity of MDP was evidenced by a negligible activity of analogs lacking most of the immunomodulating activities of MDP.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6822426      PMCID： PMC347960          DOI： 10.1128/iai.39.1.449-451.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  9 in total

1.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

2.  Human mononuclear leukocyte chemotaxis: a quantitative assay for humoral and cellular chemotactic factors.

Authors:  R Snyderman; L C Altman; M S Hausman; S E Mergenhagen
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

3.  Inhibition of macrophage migration by synthetic muramyl dipeptide.

Authors:  Y Yamamoto; S Nagao; A Tanaka; T Koga; K Onoue
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

4.  Rapid quantitation of neutrophil chemotaxis: use of a polyvinylpyrrolidone-free polycarbonate membrane in a multiwell assembly.

Authors:  L Harvath; W Falk; E J Leonard
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

5.  A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration.

Authors:  W Falk; R H Goodwin; E J Leonard
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

6.  Inhibition of macrophage migration by muramyl peptides.

Authors:  S Nagao; A Tanaka; Y Yamamoto; T Koga; K Onoue; T Shiba; K Kusumoto; S Kotani
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

7.  Stimulation of migration of human monocytes by bacterial cell walls and muramyl peptides.

Authors:  T Ogawa; S Kotani; K Fukuda; Y Tsukamoto; M Mori; S Kusumoto; T Shiba
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

8.  Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor.

Authors:  S H Zigmond; J G Hirsch
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

9.  The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes.

Authors:  S BOYDEN
Journal:  J Exp Med       Date:  1962-03-01       Impact factor: 14.307
  9 in total
  6 in total

1.  Novel biological property of pertussis toxin: chemotactic activity on human monocytes.

Authors:  T Ogawa; H Takada; S Kotani; H Sato; Y Sato
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

2.  Rabbit granulomatous enterocolitis induced by injection of muramyl dipeptide emulsified with Freund's incomplete adjuvant.

Authors:  K Kuroe; Y Haga; O Funakoshi; I Mizuki; K Kanazawa; Y Yoshida
Journal:  J Gastroenterol       Date:  1995-08       Impact factor: 7.527

3.  Detection of muramic acid in a carbohydrate fraction of human spleen.

Authors:  M A Hoijer; M J Melief; C G van Helden-Meeuwsen; F Eulderink; M P Hazenberg
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

4.  Granuloma formation by muramyl dipeptide associated with branched fatty acids, a structure probably essential for tubercle formation by Mycobacterium tuberculosis.

Authors:  K Emori; S Nagao; N Shigematsu; S Kotani; M Tsujimoto; T Shiba; S Kusumoto; A Tanaka
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

5.  Immunobiological activities of synthetic lipid A analogs and related compounds as compared with those of bacterial lipopolysaccharide, re-glycolipid, lipid A, and muramyl dipeptide.

Authors:  S Kotani; H Takada; M Tsujimoto; T Ogawa; Y Mori; M Sakuta; A Kawasaki; M Inage; S Kusumoto; T Shiba; N Kasai
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

6.  Generating neutralizing antibodies, Th1 response and MHC non restricted immunogenicity of HIV-I env and gag peptides in liposomes and ISCOMs with in-built adjuvanticity.

Authors:  Lokesh Agrawal; W Haq; Carl Veith Hanson; D Nageswara Rao
Journal:  J Immune Based Ther Vaccines       Date:  2003-11-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.